Sign Up to like & get recommendations! 2
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.46519
Abstract: Key Points Question Does a clinical decision support system (CDSS) proven to reduce cardiovascular risk in integrated care settings also reduce cardiovascular risk in community health centers? Findings In this cluster randomized clinical trial of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.3849
Abstract: Key Points Question What is the risk of cardiovascular disease associated with different amounts of habitual alcohol consumption? Findings In this cohort study of 371 463 individuals, genetic evidence supported a nonlinear, consistently risk-increasing association between… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.51094
Abstract: Key Points Question Do patients with anorexia nervosa (AN) have an increased risk of cardiovascular conditions? Findings In this cohort study including 2081 patients with AN and 20 810 matched controls, the AN group had an… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA Neurology"
DOI: 10.1001/jamaneurol.2019.1812
Abstract: Key Points Question Is the risk of cardiovascular disease greater in women with idiopathic intracranial hypertension than in women of the same age and body mass index but without idiopathic intracranial hypertension? Findings In this… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14875
Abstract: This study aimed to investigate the association between the time to achieve walkability after cardiac surgery and the risk of cardiovascular disease after hospital discharge. read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.3448
Abstract: The risk of cardiovascular events (CVEs) with alendronate use in real‐world hip fracture patients is unknown. This study aimed to investigate the risk of CVE with and without use of alendronate in patients with hip… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Journal of Cachexia, Sarcopenia and Muscle"
DOI: 10.1002/jcsm.13564
Abstract: Dynapenic obesity is a condition characterized by high adiposity levels combined with muscle dysfunction. Although high adiposity and muscle loss/dysfunction are thought to synergistically increase the risk of cardiovascular disease (CVD), few studies have addressed… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Molecular Genetics & Genomic Medicine"
DOI: 10.1002/mgg3.2418
Abstract: Loss‐of‐function (LOF) variants of the angiopoietin‐like 3 (ANGPTL3) gene are reported to be associated with serum triglyceride (TG) and high‐density lipoprotein cholesterol (HDL‐C) concentrations and thereby affect the risk of cardiovascular disease (CVD). read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Obesity"
DOI: 10.1002/oby.22725
Abstract: Quantifying risk for cardiovascular disease (CVD) events among adolescents is difficult owing to the long latent period between risk factor development and disease outcomes. This study examined the 30‐year CVD event risk among adolescents with… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Diabetologia"
DOI: 10.1007/s00125-019-4895-0
Abstract: Aims/hypothesisReversion from prediabetes to normoglycaemia is accompanied by an improvement in cardiovascular risk factors, but it is unclear whether this translates into a reduction in risk of cardiovascular disease (CVD) events or death. Hence, we… read more here.